Atlas Trials

Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients

Clinical trial NCT02639143 · COMPLETED

Trial details

NCT number
NCT02639143
Sponsor
First Affiliated Hospital of Harbin Medical University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
InflammationThrombosis
Start date
2015-12-01
Primary completion
2017-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.